IM Cannabis Corp. (IMCC) NASDAQ
0.29
-0.027747(-8.66%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.29
-0.027747(-8.66%)
Currency In USD
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
95
First IPO Date
May 20, 2020
| Name | Title | Pay | Year Born |
| Eyal Fisher | Chief Executive Officer of the IMC Holdings | 215,243 | N/A |
| Richard Balla | Chief Executive Officer of Adjupharm | 229,707 | 1986 |
| Oren Shuster | Chief Executive Officer & Executive Director | 381,281 | 1969 |
| Advocate Michal Lebovitz Nissimov | General Counsel & Secretary | 138,715 | N/A |
| Asi Levi | Chief Financial Officer | 159,806 | 1980 |
| Anna Taranko | Director Investor & Public Relations | 0 | N/A |
IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel, Germany, and Canada. It offers cannabis flowers and strain specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, and pressed hash offerings under the WAGNERS and Highland Grow brands. The company serves medical patients and adult-use recreational consumers. IM Cannabis Corp. is headquartered in Tel Aviv-Yafo, Israel.